Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Report ID | 167320 |
Drug Identification Number | 02330547 |
Brand name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
Common or Proper name | PIP/TAZO |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | TAZOBACTAM PIPERACILLIN |
Strength(s) | 1.5G 12G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1PSOIJ |
ATC code | J01CR |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-08-18 |
Estimated end date | 2022-09-23 |
Actual end date | 2022-09-21 |
Shortage status | Resolved |
Updated date | 2022-09-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-09-22 | English | Compare |
v5 | 2022-09-21 | French | Compare |
v4 | 2022-09-21 | English | Compare |
v3 | 2022-08-18 | French | Compare |
v2 | 2022-08-18 | English | Compare |
v1 | 2022-08-18 | English | Compare |
Showing 1 to 6 of 6